Gene · 10643
Papers3,038
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 3,038
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cumulative effects of weakly repressive regulatory regions in the 3' UTR maintain PD-1 expression homeostasis in mammals. | Commun Biol | 2023 | 37202440 | PubTator, text mining | PubMed |
| The cancer-testis lncRNA LINC01977 promotes HCC progression by interacting with RBM39 to prevent Notch2 ubiquitination. | Cell Death Discov | 2023 | 37198207 | PubTator, text mining | PubMed |
| Comprehensive analysis of m6A related gene mutation characteristics and prognosis in colorectal cancer. | BMC Med Genomics | 2023 | 37194014 | PubTator, text mining | PubMed |
| Intertwined regulation between RNA m6A modification and cancer metabolism. | Cell Insight | 2023 | 37192910 | PubTator, text mining | PubMed |
| The Regulatory Network of METTL3 in the Nervous System: Diagnostic Biomarkers and Therapeutic Targets. | Biomolecules | 2023 | 37189411 | PubTator, text mining | PubMed |
| Multi-label transcriptional classification of colorectal cancer reflects tumor cell population heterogeneity. | Genome Med | 2023 | 37189167 | PubTator, text mining | PubMed |
| IGF2BP3 promotes adult myocardial regeneration by stabilizing MMP3 mRNA through interaction with m6A modification. | Cell Death Discov | 2023 | 37188676 | PubTator, text mining | PubMed |
| ALDOB represents a potential prognostic biomarker for patients with clear cell renal cell carcinoma. | Transl Androl Urol | 2023 | 37181232 | PubTator, text mining | PubMed |
| N6-methyladenosine reader IGF2BP3 as a prognostic Biomarker contribute to malignant progression of glioma. | Transl Cancer Res | 2023 | 37180667 | PubTator, text mining | PubMed |
| The necroptosis related gene LGALS3 can be used as a biomarker for the adverse progression from chronic HBV infection to HCC. | Front Immunol | 2023 | 37180150 | PubTator, text mining | PubMed |
| FRA-1 as a Regulator of EMT and Metastasis in Breast Cancer. | Int J Mol Sci | 2023 | 37176013 | PubTator, text mining | PubMed |
| ARHGAP11A Is a Novel Prognostic and Predictive Biomarker Correlated with Immunosuppressive Microenvironment in Clear Cell Renal Cell Carcinoma. | Int J Mol Sci | 2023 | 37175461 | PubTator, text mining | PubMed |
| m6 A-Dependent Modulation via IGF2BP3/MCM5/Notch Axis Promotes Partial EMT and LUAD Metastasis. | Adv Sci (Weinh) | 2023 | 37171793 | PubTator, text mining | PubMed |
| GPX8 deficiency-induced oxidative stress reprogrammed m6A epitranscriptome of oral cancer cells. | Epigenetics | 2023 | 37170591 | PubTator, text mining | PubMed |
| The m6A/m5C/m1A regulator genes signature reveals the prognosis and is related with immune microenvironment for hepatocellular carcinoma. | BMC Gastroenterol | 2023 | 37170222 | PubTator, text mining | PubMed |
| RNA N6-methyladenosine reader IGF2BP3 interacts with MYCN and facilitates neuroblastoma cell proliferation. | Cell Death Discov | 2023 | 37156775 | PubTator, text mining | PubMed |
| The molecular mechanisms in prenatal drug exposure-induced fetal programmed adult cardiovascular disease. | Front Pharmacol | 2023 | 37153765 | PubTator, text mining | PubMed |
| Diagnosis and biomarkers for ocular tuberculosis: From the present into the future. | Theranostics | 2023 | 37153734 | PubTator, text mining | PubMed |
| m6A modification on the fate of colorectal cancer: functions and mechanisms of cell proliferation and tumorigenesis. | Front Oncol | 2023 | 37152066 | PubTator, text mining | PubMed |
| Deubiquitinase USP13 regulates glycolytic reprogramming and progression in osteosarcoma by stabilizing METTL3/m6A/ATG5 axis. | Int J Biol Sci | 2023 | 37151889 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10643/papers?page=36